Category: Vaccine Headlines
Covid Vaccine Makers’ Stocks Crash To Multiyear Lows Monday As Sales Keep Sliding
Forbes Moderna and BioNTech shares both cratered to their lowest price in years Monday as the companies behind the most widely-circulated mRNA Covid-19 vaccines grapple with investor disappointment with crashing revenues. BioNTech and Moderna’s stocks fell 8% and 6%, respectively, a decline spurred by BioNTech’s earnings report revealing the German firm’s sales fell 95% year-over-year […]
Aug 8, 2023
UK Health Security Agency unveils world-leading Vaccine Development and Evaluation Centre
Medical News.Net The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide. The center is situated at the UKHSA’s Porton Down site, where it is co-located with other services delivered separately […]
Aug 8, 2023
Pfizer 2Q numbers tumble and COVID-19 vaccine, treatment sales dry up
Washington Post Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023. Pfizer recorded no U.S. sales of its treatment, Paxlovid, in the recently completed quarter, as the company shifts to selling the pills on the commercial market after contracting […]
Aug 1, 2023
Rare Links Between COVID Vaccines and Adverse Events Studied
MedpageToday Two Yale University researchers want to understand why symptoms that emerge rarely after COVID-19 vaccines occur. Persistent symptoms after vaccination — sometimes called “long vax” — are similar to those reported with long COVID, including small-fiber neuropathy and postural orthostatic tachycardia syndrome (POTS ). But studies have largely shown that the risk of post-vaccine events do […]
Aug 1, 2023
GSK’s Arexvy to lead new RSV vaccines sales race with Moderna a close second: report
Fierce Pharma We waited years for working RSV vaccines and in 2023, in the space of just a few weeks, we had two come all at once, with another on the horizon and a fresh approval for an RSV prevention med. But how will the RSV market shake out? Well, the analysts at GlobalData crunched […]
Jul 25, 2023
Preparing for the next pandemic before it starts
NIH In March 2020, the world changed in the blink of an eye as countries around the world locked down to slow the spread of COVID-19. This often deadly disease, caused by a previously unknown coronavirus called SARS-CoV-2, seeded outbreaks across the globe in record time. By the end of 2022, it had killed more […]
Jul 25, 2023
After a historic downturn due to the pandemic, childhood immunizations are improving
NPR Fewer children around the world missed receiving routine vaccinations in 2022 compared to the year before, indicating a rebound in childhood immunizations following the COVID-19 pandemic, according to new statistics released by the World Health Organization and UNICEF. Last year, 20.5 million children did not get one or more rounds of the DTaP (diphtheria, […]
Jul 18, 2023
COVID-19 Vaccines Saved Dementia Patients’ Lives in Nursing Homes
UCSF Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, yet remained high for those living at home, according to a new study led by UC San Francisco. The nationwide study published July 17, 2023 in JAMA Neurology, is the first to use data from […]
Jul 18, 2023
HHS CDC Recommendation Follows the Advisory Committee on Immunization Practices’ (ACIP) Recommendations for the Use of New GSK and Pfizer RSV Vaccines for People Ages 60 Years and Older Today, in response to the Centers for Disease Control and Prevention’s (CDC) recommendation of the Respiratory Syncytial Virus (RSV) vaccine for seniors over 60, U.S. Department of […]
Jul 5, 2023
JAMA On June 15, members of the US Food and Drug Administration’s (FDA) Vaccine and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend updating the COVID-19 vaccine composition to a monovalent XBB lineage. On June 16, the FDA announced that it had advised manufacturers planning to update their COVID-19 vaccines that they should specifically target XBB.1.5. Scientists […]
Jul 5, 2023
